Analysts' Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)

TipRanksMay 15 15:40 ET

Nomura Adjusts Asymchem Laboratories' Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy

MT NewswiresApr 26 04:44 ET

Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)

TipRanksApr 5 05:40 ET

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.16 From HK$6.63, Keeps at Buy

MT NewswiresMar 15 06:23 ET

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$9.41 From HK$8.98, Keeps at Buy

MT NewswiresMar 14 08:47 ET

Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to HK$90.12 From HK$134.59, Keeps at Buy

MT NewswiresMar 4 05:35 ET

HUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth Potential

TipRanksFeb 28 16:55 ET

Nomura Adjusts Innovent Biologics' Price Target to HK$55.31 From HK$54.51, Keeps at Buy

MT NewswiresFeb 26 04:12 ET

Maintaining Hold on HUTCHMED: Mixed FRUTIGA Results and Fair Valuation Limit Upside

TipRanksFeb 6 23:36 ET

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), HUTCHMED (HCM) and Plus Therapeutics (PSTV)

TipRanksNov 28, 2023 16:40 ET

Deutsche Bank Upgrades HUTCHMED (China) to Buy, Raises Price Target to $22.1

BenzingaNov 24, 2023 05:08 ET

HUTCHMED (China) Analyst Ratings

BenzingaNov 24, 2023 04:59 ET

HUTCHMED's Global Expansion and New Product Launches Bolster Buy Rating: An Analysis of Growth Prospects and Market Potential

TipRanksNov 24, 2023 03:55 ET

HUTCHMED (China) Analyst Ratings

BenzingaNov 10, 2023 11:03 ET

Analysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)

TipRanksNov 9, 2023 09:22 ET

Nomura Adjusts Innovent Biologics' Price Target to HK$54.51 From HK$45.73, Keeps at Buy

MT NewswiresNov 6, 2023 05:27 ET

INNOVENT BIOLOGICS(1801.HK):MAZDUTIDE(9MG)CONTINUES TO SHOW ITS BIC POTENTIAL WITH 48-WEEK RESULTS

招银国际Oct 31, 2023 02:16 ET

Nomura Adjusts Pharmaron's Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy

MT NewswiresOct 25, 2023 06:14 ET

Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$134.59 From HK$130.30, Keeps at Buy

MT NewswiresOct 25, 2023 06:10 ET

Cantor Fitzgerald Reiterates Overweight on HUTCHMED (China), Maintains $50 Price Target

BenzingaSep 5, 2023 09:58 ET